1
|
Nweke M, Nombeko M, Govender N, Akinpelu A, Ukwuoma M, Ogunniyi A. Aerobic exercise for HIV-associated neurocognitive disorders in individuals on antiretroviral therapy: A randomised controlled trial. Clin Rehabil 2022; 36:1601-1612. [PMID: 35850533 DOI: 10.1177/02692155221114587] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
INTRODUCTION The increasing burden of self-limiting forms of HIV-associated neurocognitive disorder (HAND) in the antiretroviral therapy era calls for adjunctive interventions. The study aimed to determine the effects of a 12-week aerobic exercise programme on HAND. METHODS This is a parallel-group, randomized controlled trial with concealed allocation and intention-to-treat analysis. This study was a clinic-based programme. Seventy-three patients with HAND were enrolled in the trial. The intervention comprised a moderate-intensity aerobic exercise, 20-60 min per session, three times per week, for twelve weeks. The control group received exercise education. Prevalence of HAND constituted the primary outcome. HAND was identified and classified following the Frascati criteria. We computed the odds ratio and number needed-to-treat to estimate the treatment effect. RESULTS There were 73 patients (38 in exercise and 35 in control arm). Individuals in the exercise arm recorded a significantly higher reduction in working memory deficit (OR = 5.14; CI = 2.6-10.4; NNT = 6) but not in attention-deficit (OR = 0.31, CI = 0.2-0.5; NNT = -5) compared to the control group at twelve-week. Reductions in attention deficit (OR = 1.55, 95 CI = 1.0-2.4; NNT = 5) and HAND prevalence (OR = 1.8, 95 CI = 1.2-2.8); NNT = 8) were significantly higher in the exercise group compared the control group at three-month. No significant between-group difference in functional independence was observed immediately after exercise (p > 0.05). DISCUSSION The neuroprotective effects of aerobic exercise appear selective and vary with cognitive abilities impaired and aerobic capacity, with a greater change occurring with improved aerobic capacity. CONCLUSION Individuals with working memory and attention deficits may benefit more from moderate-intensity aerobic exercise.
Collapse
Affiliation(s)
- Martins Nweke
- Department of Physiotherapy, School of Healthcare, Faculty of Health Sciences, 56410University of Pretoria, Pretoria South Africa
| | - Mshunqane Nombeko
- Department of Physiotherapy, School of Healthcare, Faculty of Health Sciences, 56410University of Pretoria, Pretoria South Africa
| | - Nalini Govender
- Department of Physiotherapy, School of Healthcare, Faculty of Health Sciences, 56410University of Pretoria, Pretoria South Africa
| | - Aderonke Akinpelu
- Department of Physiotherapy, School of Healthcare, Faculty of Health Sciences, 56410University of Pretoria, Pretoria South Africa
| | - Maryjane Ukwuoma
- Department of Physiotherapy, School of Healthcare, Faculty of Health Sciences, 56410University of Pretoria, Pretoria South Africa
| | - Adesola Ogunniyi
- Department of Physiotherapy, School of Healthcare, Faculty of Health Sciences, 56410University of Pretoria, Pretoria South Africa
| |
Collapse
|
2
|
Abstract
Endothelins were discovered more than thirty years ago as potent vasoactive compounds. Beyond their well-documented cardiovascular properties, however, the contributions of the endothelin pathway have been demonstrated in several neuroinflammatory processes and the peptides have been reported as clinically relevant biomarkers in neurodegenerative diseases. Several studies report that endothelin-1 significantly contributes to the progression of neuroinflammatory processes, particularly during infections in the central nervous system (CNS), and is associated with a loss of endothelial integrity at the blood brain barrier level. Because of the paucity of clinical trials with endothelin-1 antagonists in several infectious and non-infectious neuroinflammatory diseases, it remains an open question whether the 21 amino acid peptide is a mediator/modulator rather than a biomarker of the progression of neurodegeneration. This review focuses on the potential roles of endothelins in the pathology of neuroinflammatory processes, including infectious diseases of viral, bacterial or parasitic origin in which the synthesis of endothelins or its pharmacology have been investigated from the cell to the bedside in several cases, as well as in non-infectious inflammatory processes such as neurodegenerative disorders like Alzheimers Disease or central nervous system vasculitis.
Collapse
|
3
|
Smit E, White E, Clark D, Churchill D, Zhang H, Collins S, Pillay D, Sabin C, Nelson M, Winston A, Jose S, Tostevin A, Dunn DT. An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs. J Antimicrob Chemother 2018; 72:2075-2082. [PMID: 28379449 PMCID: PMC5890671 DOI: 10.1093/jac/dkx091] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2016] [Accepted: 02/28/2017] [Indexed: 11/13/2022] Open
Abstract
Objectives: HIV-1 subtype C might have a greater propensity to develop K65R mutations in patients with virological failure compared with other subtypes. However, the strong association between viral subtype and confounding factors such as exposure groups and ethnicity affects the calculation of this propensity. We exploited the diversity of viral subtypes within the UK to undertake a direct comparative analysis. Patients and methods: We analysed only sequences with major IAS-defined mutations from patients with virological failure. Prevalence of K65R was related to subtype and exposure to the NRTIs that primarily select for this mutation (tenofovir, abacavir, didanosine and stavudine). A multivariate logistic regression model quantified the effect of subtype on the prevalence of K65R, adjusting for previous and current exposure to all four specified drugs. Results: Subtype B patients (n = 3410) were mostly MSM (78%) and those with subtype C (n = 810) were mostly heterosexual (82%). K65R was detected in 7.8% of subtype B patients compared with 14.2% of subtype C patients. The subtype difference in K65R prevalence was observed irrespective of NRTI exposure and K65R was frequently selected by abacavir, didanosine and stavudine in patients with no previous exposure to tenofovir. Multivariate logistic regression confirmed that K65R was significantly more common in subtype C viruses (adjusted OR = 2.02, 95% CI = 1.55–2.62, P < 0.001). Conclusions: Patients with subtype C HIV-1 have approximately double the frequency of K65R in our database compared with other subtypes. The exact clinical implications of this finding need to be further elucidated.
Collapse
Affiliation(s)
- Erasmus Smit
- Public Health Laboratory Birmingham, Public Health England, Heartlands Hospital, Birmingham, UK
| | - Ellen White
- MRC CTU at UCL, University College London, London, UK
| | | | - Duncan Churchill
- Brighton and Sussex University Hospitals NHS Trust, Brighton, UK
| | - Hongyi Zhang
- Public Health Laboratory Cambridge, Public Health England, Addenbrooke's Hospital, Cambridge, UK
| | | | - Deenan Pillay
- Research Department of Infection, Division of Infection and Immunity, University College London, London, UK.,Wellcome Trust Africa Centre for Health and Population Sciences, University of KwaZulu Natal, Mtubatuba, South Africa
| | - Caroline Sabin
- Research Department of Infection and Population Health London, University College London, London, UK
| | - Mark Nelson
- Chelsea and Westminster Hospital, London, UK
| | - Alan Winston
- Section of Infectious Diseases, Department of Medicine, Imperial College London, London, UK
| | - Sophie Jose
- Research Department of Infection and Population Health London, University College London, London, UK
| | - Anna Tostevin
- Research Department of Infection and Population Health London, University College London, London, UK
| | - David T Dunn
- Research Department of Infection and Population Health London, University College London, London, UK
| | | |
Collapse
|
4
|
Babiloni C, Noce G, Pennica A, Onorati P, Capotosto P, Del Percio C, Roma P, Correr V, Piccinni E, Toma G, Soricelli A, Di Campli F, Gianserra L, Ciullini L, Aceti A, Teti E, Sarmati L, Crocetti G, Ferri R, Catania V, Pascarelli MT, Andreoni M, Ferracuti S. Cortical sources of resting state electroencephalographic rhythms probe brain function in naïve HIV individuals. Clin Neurophysiol 2017; 129:431-441. [PMID: 29304418 DOI: 10.1016/j.clinph.2017.12.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2016] [Revised: 10/31/2017] [Accepted: 12/05/2017] [Indexed: 10/18/2022]
Abstract
OBJECTIVE Here we evaluated the hypothesis that resting state electroencephalographic (EEG) cortical sources correlated with cognitive functions and discriminated asymptomatic treatment-naïve HIV subjects (no AIDS). METHODS EEG, clinical, and neuropsychological data were collected in 103 treatment-naïve HIV subjects (88 males; mean age 39.8 years ± 1.1 standard error of the mean, SE). An age-matched group of 70 cognitively normal and HIV-negative (Healthy; 56 males; 39.0 years ± 2.0 SE) subjects, selected from a local university archive, was used for control purposes. LORETA freeware was used for EEG source estimation in fronto-central, temporal, and parieto-occipital regions of interest. RESULTS Widespread sources of delta (<4 Hz) and alpha (8-12 Hz) rhythms were abnormal in the treatment-naïve HIV group. Fronto-central delta source activity showed a slight but significant (p < 0.05, corrected) negative correlation with verbal and semantic test scores. So did parieto-occipital delta/alpha source ratio with memory and composite cognitive scores. These sources allowed a moderate classification accuracy between HIV and control individuals (area under the ROC curves of 70-75%). CONCLUSIONS Regional EEG abnormalities in quiet wakefulness characterized treatment-naïve HIV subjects at the individual level. SIGNIFICANCE This EEG approach may contribute to the management of treatment-naïve HIV subjects at risk of cognitive deficits.
Collapse
Affiliation(s)
- Claudio Babiloni
- Department of Physiology and Pharmacology, University of Rome "La Sapienza", Rome, Italy; Institute for Research and Medical Care, IRCCS San Raffaele Pisana, Rome, Italy.
| | - Giuseppe Noce
- Department of Integrated Imaging, IRCCS SDN, Naples, Italy
| | - Alfredo Pennica
- Infectious Diseases, Faculty of Medicine and Psychology, University of Rome "La Sapienza", Rome, Italy
| | - Paolo Onorati
- Department of Physiology and Pharmacology, University of Rome "La Sapienza", Rome, Italy; Institute for Research and Medical Care, IRCCS San Raffaele Pisana, Rome, Italy
| | - Paolo Capotosto
- Department of Neuroscience, Imaging and Clinical Sciences, and ITAB-Institute of Advanced Biomedical Technologies "G. d'Annunzio" University of Chieti and Pescara, Chieti, Italy
| | | | - Paolo Roma
- Department of Neurology and Psychiatry, University of Rome "La Sapienza", Rome, Italy
| | - Valentina Correr
- Department of Neurology and Psychiatry, University of Rome "La Sapienza", Rome, Italy
| | - Elisa Piccinni
- Department of Neurology and Psychiatry, University of Rome "La Sapienza", Rome, Italy
| | - Ginevra Toma
- Department of Physiology and Pharmacology, University of Rome "La Sapienza", Rome, Italy
| | - Andrea Soricelli
- Department of Integrated Imaging, IRCCS SDN, Naples, Italy; Department of Motor Sciences and Healthiness, University of Naples Parthenope, Naples, Italy
| | - Francesco Di Campli
- Infectious Diseases, Faculty of Medicine and Psychology, University of Rome "La Sapienza", Rome, Italy
| | - Laura Gianserra
- Infectious Diseases, Faculty of Medicine and Psychology, University of Rome "La Sapienza", Rome, Italy
| | - Lorenzo Ciullini
- Infectious Diseases, Faculty of Medicine and Psychology, University of Rome "La Sapienza", Rome, Italy
| | - Antonio Aceti
- Infectious Diseases, Faculty of Medicine and Psychology, University of Rome "La Sapienza", Rome, Italy
| | - Elisabetta Teti
- Clinical Infectious Diseases, University of Rome "Tor Vergata", Rome, Italy
| | - Loredana Sarmati
- Clinical Infectious Diseases, University of Rome "Tor Vergata", Rome, Italy
| | - Gloria Crocetti
- Infectious Diseases, Faculty of Medicine and Psychology, University of Rome "La Sapienza", Rome, Italy
| | - Raffaele Ferri
- Department of Neurology, IRCCS Oasi Institute for Research on Mental Retardation and Brain Aging, Troina, Enna, Italy
| | - Valentina Catania
- Department of Neurology, IRCCS Oasi Institute for Research on Mental Retardation and Brain Aging, Troina, Enna, Italy
| | - Maria Teresa Pascarelli
- Department of Neurology, IRCCS Oasi Institute for Research on Mental Retardation and Brain Aging, Troina, Enna, Italy
| | - Massimo Andreoni
- Clinical Infectious Diseases, University of Rome "Tor Vergata", Rome, Italy
| | - Stefano Ferracuti
- Department of Neurology and Psychiatry, University of Rome "La Sapienza", Rome, Italy
| |
Collapse
|
5
|
Babiloni C, Pennica A, Capotosto P, Onorati P, Muratori C, Ferracuti S, Roma P, Correr V, Piccinni E, Noce G, Del Percio C, Cordone S, Limatola C, Soricelli A, Di Campli F, Gianserra L, Ciullini L, Aceti A, Viscione M, Teti E, Sarmati L, Andreoni M. Brain and cognitive functions in two groups of naïve HIV patients selected for a different plan of antiretroviral therapy: A qEEG study. Clin Neurophysiol 2016; 127:3455-3469. [PMID: 27716535 DOI: 10.1016/j.clinph.2016.09.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2016] [Revised: 08/24/2016] [Accepted: 09/04/2016] [Indexed: 11/15/2022]
Abstract
OBJECTIVE Cortical sources of electroencephalographic (EEG) rhythms were investigated in two sub-populations of naïve HIV subjects, grouped based on clinical criteria to receive different combination anti-retroviral therapies (cARTs). These EEG sources were hypothesized to reflect beneficial effects of both regimes. METHODS Eyes-closed resting state EEG data were collected in 19 (Group A) and 39 (Group B) naïve HIV subjects at baseline (i.e. pre-treatment; T0) and after 5months of cART (T5). Compared with the Group A, the Group B was characterized by slightly worse serological parameters and higher cardiovascular risk. At T0, mean viral load (VL) and CD4 count were 87,694copies/ml and 435cells/μl in the Group A and 187,370copies/ml and 331cells/μl in the Group B. The EEG data were also collected in 50 matched control HIV-negative subjects. Cortical EEG sources were assessed by LORETA software. RESULTS Compared to the Control Group, the HIV Groups showed lower alpha (8-12Hz) source activity at T0 while the Group B also exhibited higher delta source activity. The treatment partially normalized alpha and delta source activity in the Group A and B, respectively, in association with improved VL, CD4, and cognitive functions. CONCLUSIONS Different cART regimens induced diverse beneficial effects in delta or alpha source activity in the two naïve HIV Groups. SIGNIFICANCE These sources might unveil different neurophysiological effects of diverse cART on brain function in naïve HIV Groups as a function of clinical status and/or therapeutic compounds.
Collapse
Affiliation(s)
- Claudio Babiloni
- Department of Physiology and Pharmacology, University of Rome "La Sapienza", Rome, Italy; IRCCS S. Raffaele Pisana, Rome, Italy.
| | - Alfredo Pennica
- Infectious Diseases, Faculty of Medicine and Psychology, University of Rome "La Sapienza", Rome, Italy
| | | | - Paolo Onorati
- Department of Physiology and Pharmacology, University of Rome "La Sapienza", Rome, Italy; IRCCS S. Raffaele Pisana, Rome, Italy
| | | | - Stefano Ferracuti
- Psychiatry, Faculty of Medicine and Psychology, University of Rome "La Sapienza", Rome, Italy
| | - Paolo Roma
- Psychiatry, Faculty of Medicine and Psychology, University of Rome "La Sapienza", Rome, Italy
| | - Valentina Correr
- Psychiatry, Faculty of Medicine and Psychology, University of Rome "La Sapienza", Rome, Italy
| | - Elisa Piccinni
- Psychiatry, Faculty of Medicine and Psychology, University of Rome "La Sapienza", Rome, Italy
| | | | | | - Susanna Cordone
- Department of Physiology and Pharmacology, University of Rome "La Sapienza", Rome, Italy
| | - Cristina Limatola
- Department of Physiology and Pharmacology, University of Rome "La Sapienza", Rome, Italy
| | - Andrea Soricelli
- IRCCS SDN, Naples, Italy; Department of Motor Sciences and Healthiness, University of Naples Parthenope, Naples, Italy
| | - Francesco Di Campli
- Infectious Diseases, Faculty of Medicine and Psychology, University of Rome "La Sapienza", Rome, Italy
| | - Laura Gianserra
- Infectious Diseases, Faculty of Medicine and Psychology, University of Rome "La Sapienza", Rome, Italy
| | - Lorenzo Ciullini
- Infectious Diseases, Faculty of Medicine and Psychology, University of Rome "La Sapienza", Rome, Italy
| | - Antonio Aceti
- Infectious Diseases, Faculty of Medicine and Psychology, University of Rome "La Sapienza", Rome, Italy
| | - Magdalena Viscione
- Clinical Infectious Diseases, University of Rome "Tor Vergata", Rome, Italy
| | - Elisabetta Teti
- Clinical Infectious Diseases, University of Rome "Tor Vergata", Rome, Italy
| | - Loredana Sarmati
- Clinical Infectious Diseases, University of Rome "Tor Vergata", Rome, Italy
| | - Massimo Andreoni
- Clinical Infectious Diseases, University of Rome "Tor Vergata", Rome, Italy
| |
Collapse
|
6
|
Babiloni C, Pennica A, Del Percio C, Noce G, Cordone S, Lopez S, Berry K, Muratori C, Ferracuti S, Roma P, Correr V, Di Campli F, Gianserra L, Ciullini L, Aceti A, Soricelli A, Teti E, Viscione M, Limatola C, Onorati P, Capotosto P, Andreoni M. Antiretroviral therapy affects the z-score index of deviant cortical EEG rhythms in naïve HIV individuals. Neuroimage Clin 2016; 12:144-56. [PMID: 27408799 PMCID: PMC4933036 DOI: 10.1016/j.nicl.2016.06.005] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2016] [Revised: 05/12/2016] [Accepted: 06/06/2016] [Indexed: 01/04/2023]
Abstract
OBJECTIVE Here we tested the effect of combined antiretroviral therapy (cART) on deviant electroencephalographic (EEG) source activity in treatment-naïve HIV individuals. METHODS Resting state eyes-closed EEG data were recorded before and after 5 months of cART in 48 male HIV subjects, who were naïve at the study start. The EEG data were also recorded in 59 age- and sex-matched healthy subjects as a control group. Frequency bands of interest included delta, theta, alpha1, alpha2 and alpha3, based on alpha frequency peak specific to each individual. They also included beta1 (13-20 Hz) and beta2 (20-30 Hz). Low-resolution brain electromagnetic tomography (LORETA) estimated EEG cortical source activity in frontal, central, temporal, parietal, and occipital regions. RESULTS Before the therapy, the HIV group showed greater parietal delta source activity and lower spatially diffuse alpha source activity compared to the control group. Thus, the ratio of parietal delta and alpha3 source activity served as an EEG marker. The z-score showed a statistically deviant EEG marker (EEG +) in 50% of the HIV individuals before therapy (p < 0.05). After 5 months of cART, delta source activity decreased, and alpha3 source activity increased in the HIV subjects with EEG + (about 50% of them showed a normalized EEG marker). CONCLUSIONS This procedure detected a deviant EEG marker before therapy and its post-therapy normalization in naïve HIV single individuals. SIGNIFICANCE The parietal delta/alpha3 EEG marker may be used to monitor cART effects on brain function in such individuals.
Collapse
Affiliation(s)
- Claudio Babiloni
- Department of Physiology and Pharmacology, University of Rome “La Sapienza”, Rome, Italy
- IRCCS S. Raffaele Pisana, Rome, Italy
| | - Alfredo Pennica
- Infectious Diseases, Faculty of Medicine and Psychology, University of Rome “La Sapienza”, Rome, Italy
| | | | | | - Susanna Cordone
- Department of Physiology and Pharmacology, University of Rome “La Sapienza”, Rome, Italy
| | - Susanna Lopez
- Department of Physiology and Pharmacology, University of Rome “La Sapienza”, Rome, Italy
| | - Ketura Berry
- Department of Physiology and Pharmacology, University of Rome “La Sapienza”, Rome, Italy
| | | | - Stefano Ferracuti
- Psychiatry, Faculty of Medicine and Psychology, University of Rome “La Sapienza”, Rome, Italy
| | - Paolo Roma
- Psychiatry, Faculty of Medicine and Psychology, University of Rome “La Sapienza”, Rome, Italy
| | - Valentina Correr
- Psychiatry, Faculty of Medicine and Psychology, University of Rome “La Sapienza”, Rome, Italy
| | - Francesco Di Campli
- Infectious Diseases, Faculty of Medicine and Psychology, University of Rome “La Sapienza”, Rome, Italy
| | - Laura Gianserra
- Infectious Diseases, Faculty of Medicine and Psychology, University of Rome “La Sapienza”, Rome, Italy
| | - Lorenzo Ciullini
- Infectious Diseases, Faculty of Medicine and Psychology, University of Rome “La Sapienza”, Rome, Italy
| | - Antonio Aceti
- Infectious Diseases, Faculty of Medicine and Psychology, University of Rome “La Sapienza”, Rome, Italy
| | - Andrea Soricelli
- IRCCS SDN, Naples, Italy
- Department of Motor Sciences and Healthiness, University of Naples Parthenope, Naples, Italy
| | - Elisabetta Teti
- Clinical Infectious Diseases, University of Rome “Tor Vergata”, Rome, Italy
| | - Magdalena Viscione
- Clinical Infectious Diseases, University of Rome “Tor Vergata”, Rome, Italy
| | - Cristina Limatola
- Department of Physiology and Pharmacology, University of Rome “La Sapienza”, Rome, Italy
| | - Paolo Onorati
- Department of Physiology and Pharmacology, University of Rome “La Sapienza”, Rome, Italy
- IRCCS S. Raffaele Pisana, Rome, Italy
| | | | - Massimo Andreoni
- Clinical Infectious Diseases, University of Rome “Tor Vergata”, Rome, Italy
| |
Collapse
|
7
|
Babiloni C, Pennica A, Del Percio C, Noce G, Cordone S, Muratori C, Ferracuti S, Donato N, Di Campli F, Gianserra L, Teti E, Aceti A, Soricelli A, Viscione M, Limatola C, Andreoni M, Onorati P. Abnormal cortical sources of resting state electroencephalographic rhythms in single treatment-naïve HIV individuals: A statistical z-score index. Clin Neurophysiol 2015; 127:1803-12. [PMID: 26762948 DOI: 10.1016/j.clinph.2015.12.007] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2014] [Revised: 10/26/2015] [Accepted: 12/05/2015] [Indexed: 01/06/2023]
Abstract
OBJECTIVE This study tested a simple statistical procedure to recognize single treatment-naïve HIV individuals having abnormal cortical sources of resting state delta (<4 Hz) and alpha (8-13 Hz) electroencephalographic (EEG) rhythms with reference to a control group of sex-, age-, and education-matched healthy individuals. Compared to the HIV individuals with a statistically normal EEG marker, those with abnormal values were expected to show worse cognitive status. METHODS Resting state eyes-closed EEG data were recorded in 82 treatment-naïve HIV (39.8 ys.±1.2 standard error mean, SE) and 59 age-matched cognitively healthy subjects (39 ys.±2.2 SE). Low-resolution brain electromagnetic tomography (LORETA) estimated delta and alpha sources in frontal, central, temporal, parietal, and occipital cortical regions. RESULTS Ratio of the activity of parietal delta and high-frequency alpha sources (EEG marker) showed the maximum difference between the healthy and the treatment-naïve HIV group. Z-score of the EEG marker was statistically abnormal in 47.6% of treatment-naïve HIV individuals with reference to the healthy group (p<0.05). Compared to the HIV individuals with a statistically normal EEG marker, those with abnormal values exhibited lower mini mental state evaluation (MMSE) score, higher CD4 count, and lower viral load (p<0.05). CONCLUSIONS This statistical procedure permitted for the first time to identify single treatment-naïve HIV individuals having abnormal EEG activity. SIGNIFICANCE This procedure might enrich the detection and monitoring of effects of HIV on brain function in single treatment-naïve HIV individuals.
Collapse
Affiliation(s)
- Claudio Babiloni
- Department of Physiology and Pharmacology, University of Rome "La Sapienza", Rome, Italy; IRCCS S. Raffaele Pisana, Rome, Italy.
| | - Alfredo Pennica
- Infectious Diseases, Faculty of Medicine and Psychology, University of Rome "La Sapienza", Rome, Italy
| | | | | | - Susanna Cordone
- Department of Physiology and Pharmacology, University of Rome "La Sapienza", Rome, Italy
| | | | - Stefano Ferracuti
- Psychiatry, Faculty of Medicine and Psychology, University of Rome "La Sapienza", Rome, Italy
| | - Nicole Donato
- Psychiatry, Faculty of Medicine and Psychology, University of Rome "La Sapienza", Rome, Italy
| | - Francesco Di Campli
- Infectious Diseases, Faculty of Medicine and Psychology, University of Rome "La Sapienza", Rome, Italy
| | - Laura Gianserra
- Infectious Diseases, Faculty of Medicine and Psychology, University of Rome "La Sapienza", Rome, Italy
| | - Elisabetta Teti
- Infectious Diseases, Faculty of Medicine and Psychology, University of Rome "La Sapienza", Rome, Italy
| | - Antonio Aceti
- Infectious Diseases, Faculty of Medicine and Psychology, University of Rome "La Sapienza", Rome, Italy
| | - Andrea Soricelli
- IRCCS SDN, Naples, Italy; Department of Motor Sciences and Healthiness, University of Naples Parthenope, Naples, Italy
| | - Magdalena Viscione
- Clinical Infectious Diseases, University of Rome "Tor Vergata", Rome, Italy
| | - Cristina Limatola
- Department of Physiology and Pharmacology, University of Rome "La Sapienza", Rome, Italy
| | - Massimo Andreoni
- Clinical Infectious Diseases, University of Rome "Tor Vergata", Rome, Italy
| | - Paolo Onorati
- Department of Physiology and Pharmacology, University of Rome "La Sapienza", Rome, Italy; IRCCS S. Raffaele Pisana, Rome, Italy
| |
Collapse
|
8
|
Synaptic Plasticity and Neurological Disorders in Neurotropic Viral Infections. Neural Plast 2015; 2015:138979. [PMID: 26649202 PMCID: PMC4663354 DOI: 10.1155/2015/138979] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2015] [Revised: 06/16/2015] [Accepted: 06/18/2015] [Indexed: 12/13/2022] Open
Abstract
Based on the type of cells or tissues they tend to harbor or attack, many of the viruses are characterized. But, in case of neurotropic viruses, it is not possible to classify them based on their tropism because many of them are not primarily neurotropic. While rabies and poliovirus are considered as strictly neurotropic, other neurotropic viruses involve nervous tissue only secondarily. Since the AIDS pandemic, the interest in neurotropic viral infections has become essential for all clinical neurologists. Although these neurotropic viruses are able to be harbored in or infect the nervous system, not all the neurotropic viruses have been reported to cause disrupted synaptic plasticity and impaired cognitive functions. In this review, we have discussed the neurotropic viruses, which play a major role in altered synaptic plasticity and neurological disorders.
Collapse
|
9
|
Hidalgo M, Atluri VSR, Nair M. Drugs of Abuse in HIV infection and neurotoxicity. Front Microbiol 2015; 6:217. [PMID: 25852673 PMCID: PMC4371755 DOI: 10.3389/fmicb.2015.00217] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2015] [Accepted: 03/03/2015] [Indexed: 11/20/2022] Open
Affiliation(s)
- Melissa Hidalgo
- Department of Immunology, Institute of NeuroImmune Pharmacology, Herbert Wertheim College of Medicine, Florida International University Miami, FL, USA
| | - Venkata S R Atluri
- Department of Immunology, Institute of NeuroImmune Pharmacology, Herbert Wertheim College of Medicine, Florida International University Miami, FL, USA
| | - Madhavan Nair
- Department of Immunology, Institute of NeuroImmune Pharmacology, Herbert Wertheim College of Medicine, Florida International University Miami, FL, USA
| |
Collapse
|
10
|
Chang SL, Connaghan KP, Wei Y, Li MD. NeuroHIV and use of addictive substances. INTERNATIONAL REVIEW OF NEUROBIOLOGY 2014; 118:403-40. [PMID: 25175871 DOI: 10.1016/b978-0-12-801284-0.00013-0] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
In the past three decades, substance abuse has been identified as a key comorbidity of human immunodeficiency virus-1 (HIV-1) infection. Many studies have found that the use and abuse of addictive substances hastens the progression of HIV-1 infection and HIV-associated neurocognitive disorders. Advances in highly active antiretroviral therapy (HAART) in the mid-1990s have been successful in limiting the HIV-1 viral load and maintaining a relatively healthy immune response, allowing the life expectancy of patients infected with HIV to approach that of the general population. However, even with HAART, HIV-1 viral proteins are still expressed and eradication of the virus, particularly in the brain, the key reservoir organ, does not occur. In the post-HAART era, the clinical challenge in the treatment of HIV infection is inflammation of the central nervous system (CNS) and its subsequent neurological disorders. To date, various explicit and implicit connections have been identified between the neuronal circuitry involved in immune responses and brain regions affected by and implicated in substance abuse. This chapter discusses past and current medical uses of prototypical substances of abuse, including morphine, alcohol, cocaine, methamphetamine, marijuana, and nicotine, and the evidence that systemic infections, particularly HIV-1 infection, cause neurological dysfunction as a result of inflammation in the CNS, which can increase the risk of substance abuse.
Collapse
Affiliation(s)
- Sulie L Chang
- Institute of NeuroImmune Pharmacology, Seton Hall University, South Orange, New Jersey, USA; Department of Biological Sciences, Seton Hall University, South Orange, New Jersey, USA.
| | - Kaitlyn P Connaghan
- Institute of NeuroImmune Pharmacology, Seton Hall University, South Orange, New Jersey, USA
| | - Yufeng Wei
- Institute of NeuroImmune Pharmacology, Seton Hall University, South Orange, New Jersey, USA
| | - Ming D Li
- Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, Virginia, USA
| |
Collapse
|